To the Editor: Breath testing using 13C-labeled octanoate allows indirect assessment of gastric emptying by monitoring 13CO2 exhaled [1, 2]. 13C-Octanoate is absorbed only after it is emptied from the stomach, and is oxidized to 13CO2 in the liver. The methodological relevance of the breath test is based on the assumption that intestinal absorption and hepatic oxidation progress so rapidly as to be bypassed effectively [1]. No one has doubted the validity of the assumption, because pulmonary 13CO2 excretion attains its peak level 10 min after direct administration of 13C-octanoate into the duodenum [1]. However, the rapid peak of 13CO2 excretion does not necessarily exclude the possibility that the slow absorption of 13C-octanoate is ongoing long after the time of peak excretion.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.